This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Catalyst Health Solutions' CEO Discusses Q4 2011 Results - Earnings Call Transcript

Catalyst Health Solutions, Inc ( CHSI)

Q4 2011 Earnings Call

February 22, 2012 8:00 AM ET


David Blair – Chairman and CEO

Rick Bates – President and COO

Tim Pearson – Chief Financial Officer


Amanda Murphy – William Blair

George Hill – Citi

Larry Marsh – Barclays Capital

Jeff Bailin – Credit Suisse

Brooks O'Neil – Dougherty & Company

Michael Minchak – JPMorgan

Rohit Sah – Oppenheimer

Robert Jones – Goldman Sachs

Andrew Schenker – Morgan Stanley

Robert Willoughby – Bank of America-Merrill Lynch

David Toung – Argus Research



Please standby. Good day, everyone. And welcome to today’s Catalyst Health Solutions, Incorporated Q4 Year End Earnings 2011 Conference Call. Today’s call is being recorded.

This conference will contain forward-looking information. Forward-looking statements are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements maybe significantly impacted by certain risks and uncertainties described in the company’s filings with the Securities and Exchange Commission.

With that said, I will now turn the conference over to the Chairman, Chief Executive Officer of Catalyst Health Solutions, Incorporated, Mr. David Blair. Please go ahead.

David Blair

Good morning. And thank you for joining our 2011 year end investor call. Rick Bates, our President and Chief Operating Officer; and Tim Pearson, our Chief Financial Officer are also joining us.

The company had an outstanding year both from a financial and an operational perspective driven by the acquisition of Walgreens Health Initiatives and strong organic growth.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 -1.15%
FB $117.58 0.73%
GOOG $693.01 0.29%
TSLA $240.76 -2.81%
YHOO $36.60 0.03%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs